Stocktoria
Dolby Laboratories, Inc. DLB
NYSE · stock · Patent Owners & Lessors · website · IPO 2005-02-17
Dolby Laboratories, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B |
| Gross profit | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.0B | $1.1B | $927.0M | $961.6M | $916.8M |
| R&D expense | $261.8M | $263.7M | $271.5M | $261.2M | $253.6M | $239.0M | $237.9M | $236.8M | $233.3M | $219.6M |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M | $218.7M | $257.1M | $183.5M | $247.1M | $231.8M |
| Interest expense | — | — | — | $394,000 | $479,000 | $186,000 | $170,000 | $198,000 | $127,000 | $125,000 |
| Income tax | $47.0M | $48.2M | $48.4M | $31.4M | $36.7M | $8.1M | $26.8M | $154.1M | $48.0M | $49.5M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M | $231.4M | $255.2M | $41.7M | $206.5M | $185.9M |
| EPS (diluted) | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 | $2.44 | $0.39 | $2.00 | $1.81 |
| Operating cash flow | $472.2M | $327.3M | $367.1M | $318.6M | $447.8M | $343.8M | $327.7M | $352.2M | $377.8M | $360.1M |
| Free cash flow | $435.9M | $297.2M | $336.7M | $270.6M | $393.3M | $277.5M | $231.4M | $279.4M | $278.2M | $259.3M |
| Cash & equivalents | $701.9M | $482.0M | $745.4M | $620.1M | $1.2B | $1.1B | $797.2M | $918.1M | $634.4M | $519.8M |
| Inventory | $30.4M | $33.7M | $35.6M | $23.5M | $11.0M | $25.6M | $32.3M | $26.2M | $25.1M | $16.4M |
| Total assets | $3.2B | $3.1B | $3.0B | $2.7B | $3.1B | $2.9B | $2.8B | $2.9B | $2.5B | $2.3B |
| Total liabilities | $595.8M | $623.0M | $607.6M | $438.5M | $501.5M | $478.9M | $508.7M | $494.9M | $389.7M | $331.4M |
| Shareholders' equity | $2.6B | $2.5B | $2.4B | $2.3B | $2.6B | $2.4B | $2.3B | $2.4B | $2.4B | $2.2B |
Growth · year-over-year · Revenue CAGR 3.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.9% | -2.0% | +3.7% | -2.1% | +10.3% | -6.4% | +17.7% | -2.4% | +5.3% | +5.7% |
| Net income growth | -2.6% | +30.5% | +9.0% | -40.7% | +34.1% | -9.3% | +511.2% | -79.8% | +11.1% | +2.5% |
| EPS growth | -2.6% | +31.2% | +13.3% | -39.1% | +32.0% | -7.8% | +525.6% | -80.5% | +10.5% | +3.4% |
| Free cash flow growth | +46.6% | -11.7% | +24.4% | -31.2% | +41.7% | +19.9% | -17.2% | +0.4% | +7.3% | +70.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-26. Facts plus Stocktoria's own computed scores — not investment advice.